Reply: "Anti-TNF Withdrawal in Inflammatory Bowel Disease With Endoscopic Healing and the Risk of Relapse"

Mahmoud, R; Savelkoul, E H J; Jharap, B; Oldenburg, B

doi:https://doi.org/10.1016/j.cgh.2022.10.028

Reply: "Anti-TNF Withdrawal in Inflammatory Bowel Disease With Endoscopic Healing and the Risk of Relapse"

DSpace/Manakin Repository

Reply: "Anti-TNF Withdrawal in Inflammatory Bowel Disease With Endoscopic Healing and the Risk of Relapse"

Mahmoud, R; Savelkoul, E H J; Jharap, B; Oldenburg, B

(2023) Clinical Gastroenterology and Hepatology, volume 21, issue 7, pp. 1967 - 1968

(Comment)

Download/Full Text

The full text of this publication is not available.

Version on publisher website for UU-students and staff

Version on publisher website

Keywords: Gastroenterology, Hepatology, Letter

DOI: https://doi.org/10.1016/j.cgh.2022.10.028

ISSN: 1542-3565

Publisher: W.B. Saunders

Note: Funding Information: Conflicts of interest This author discloses the following: Bas Oldenburg received research grants from AbbVie, Celltrion, Ferring, Takeda, Galapagos, and Pfizer; and has served on advisory boards for Cablon, Pfizer, BMS, Janssen, MSD, Takeda, and Galapagos. The remaining authors disclose no conflicts.

(Peer reviewed)